38492 Federal Register / Vol. 86, No. 137 / Wednesday, July 21, 2021 / Notices 

(3) Agency management and 

supervisory costs, 

(4) Costs of enforcement, research, 

and establishment of regulations and 

guidance, 

(5) Use of electronic data processing 

equipment to collect and maintain 

information—the actual cost of the 

service, including computer search 

time, runs and printouts, and 

(6) Any other direct or indirect costs 

related to the provision of services.’’ 

The Department will continue to 

review the user fees periodically as 

required by Office of Management and 

Budget Circular Number A–25 and will 

revise fees as necessary. Any future 

changes in user fees and their effective 

dates will be announced in the Federal 

Register. 

Diana Espinosa, 

Acting Administrator. 

[FR Doc. 2021–15514 Filed 7–20–21; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Twelfth Meeting of the National Clinical 

Care Commission 

AGENCY: Office on Women’s Health, 

Office of the Assistant Secretary for 

Health, Office of the Secretary, 

Department of Health and Human 

Services. 

ACTION: Notice. 

SUMMARY: The National Clinical Care 

Commission (the Commission) will 

conduct its twelfth and final meeting 

virtually on September 8, 2021. The 

Commission is charged to evaluate and 

make recommendations to the U.S. 

Department of Health and Human 

Services (HHS) Secretary and Congress 

regarding improvements to the 

coordination and leveraging of federal 

programs related to diabetes and its 

complications. 

DATES: The final meeting will take place 

September 8, 2021 from 1 p.m. to 

approximately 6 p.m. Eastern Time (ET). 

ADDRESSES: The meeting will be held 

online via webinar. To register to attend 

the meeting, please visit the registration 

website at https://

kauffmaninc.adobeconnect.com/ 

nccc12_2021/event/event_info.html. 

FOR FURTHER INFORMATION CONTACT: Kara 

Elam, Ph.D., MPH, MS, Designated 

Federal Officer, National Clinical Care 

Commission, U.S. Department of Health 

and Human Services, Office on 

Women’s Health, 200 Independence 

Ave. SW, 7th floor, Washington DC, 

20201, Phone: (240) 435–9438, Email: 

Kara.Elam@hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

National Clinical Care Commission Act 

(Pub. L. 115–80) requires the HHS 

Secretary to establish the National 

Clinical Care Commission. The 

Commission consists of representatives 

of specific federal agencies and nonfederal individuals who represent 

diverse disciplines and views. The 

Commission will evaluate and make 

recommendations to the HHS Secretary 

and Congress regarding improvements 

to the coordination and leveraging of 

federal programs related to diabetes and 

its complications. 

During the meeting, the Commission 

will vote to approve the final report to 

be submitted to Congress. The final 

meeting agenda will be available prior 

to the meeting at https://health.gov/ourwork/health-care-quality/nationalclinical-care-commission/meetings. 

Public Participation at Meeting: The 

Commission invites public comment on 

issues related to the Commission’s 

charge. There will be an opportunity for 

limited oral comments (each no more 

than 3 minutes in length) at this virtual 

meeting. Virtual attendees who plan to 

provide oral comments at the 

Commission meeting during a 

designated time must register prior to 

the meeting at https://

kauffmaninc.adobeconnect.com/ 

nccc12_2021/event/event_info.html. 

Written comments are welcome 

throughout the entire development 

process of the Commission’s work and 

may be emailed to OHQ@hhs.gov. 

Written comments should not exceed 

three pages in length. 

Individuals who need special 

assistance, such as sign language 

interpretation or other reasonable 

accommodations, should indicate the 

special accommodation when 

registering online or by notifying 

Jennifer Gillissen at jennifer.gillissen@

kauffmaninc.com by August 30, 2021. 

Authority: The National Clinical Care 

Commission is required under the 

National Clinical Care Commission Act 

(Pub. L. 115–80). The Commission is 

governed by provisions of the Federal 

Advisory Committee Act (FACA), Public 

Law 92–463, as amended (5 U.S.C., 

App.) which sets forth standards for the 

formation and use of federal advisory 

committees. 

Dated: July 14, 2021. 

Dorothy A. Fink, 

Deputy Assistant Secretary for Women’s 

Health. 

[FR Doc. 2021–15507 Filed 7–20–21; 8:45 am] 

BILLING CODE 4150–32–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; Clinical 

Courses. 

Date: August 30, 2021. 

Time: 10:00 a.m. to 11:00 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Bethesda, MD 20892 (Video Meeting). 

Contact Person: Greg Bissonette, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, National Institute on Aging, National 

Institutes of Health, 7201 Wisconsin Avenue, 

Gateway Building, Suite 2W200, Bethesda, 

MD 20892, 301–402–1622, bissonettegb@

mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: July 15, 2021. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–15450 Filed 7–20–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 


jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 86, No. 137 / Wednesday, July 21, 2021 / Notices 38493 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Clinical 

Trials in Alzheimer’s Disease. 

Date: July 27, 2021. 

Time: 11:00 a.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Telephone Conference 

Call). 

Contact Person: Sara Louise Hargrave, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3170, 

Bethesda, MD 20892, (301) 443–7193, 

hargravesl@mail.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: July 15, 2021. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–15449 Filed 7–20–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; RFA 

Review: Limited Competition to Convert the 

CNS HIV Antiretroviral Therapy Effects 

Research (CHARTER) Study Cohort to a 

Research Resource. 

Date: August 6, 2021. 

Time: 1:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Telephone 

Conference Call). 

Contact Person: Nicholas Gaiano, Ph.D., 

Review Branch Chief, Division of Extramural 

Activities, National Institute of Mental 

Health, NIH, Neuroscience Center/Room 

6150/MSC 9606, 6001 Executive Boulevard, 

Bethesda, MD 20892–9606, 301–443–2742, 

nick.gaiano@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; 

Mental Health Services Research Special 

Emphasis Panel. 

Date: August 11, 2021. 

Time: 1:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Telephone 

Conference Call). 

Contact Person: Nicholas Gaiano, Ph.D., 

Review Branch Chief, Division of Extramural 

Activities, National Institute of Mental 

Health, NIH, Neuroscience Center/Room 

6150/MSC 9606, 6001 Executive Boulevard, 

Bethesda, MD 20892–9606, 301–443–2742, 

nick.gaiano@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.242, Mental Health Research 

Grants, National Institutes of Health, HHS) 

Dated: July 15, 2021. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–15445 Filed 7–20–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel; Contraceptive 

Development Research Centers Program 

(P50). 

Date: July 20, 2021. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development, National Institutes of Health, 

6710B Rockledge Drive, Room 2125B, 

Bethesda, MD 20892 (Video Assisted 

Meeting). 

Contact Person: Derek J. McLean, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development, National Institutes of Health, 

6710B Rockledge Drive, Room 2125B, 

Bethesda, MD 20892, (301) 443–5082, 

derek.mcLean@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel; Population Health 

Improvement. 

Date: July 27, 2021. 

Time: 11:00 a.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development, National Institutes of Health, 

6710B Rockledge Drive, Room 2131B, 

Bethesda, MD 20892 (Video Assisted 

Meeting). 

Contact Person: Jolanta Maria Topczewska, 

Ph.D., Scientific Review Officer, Scientific 

Review Branch, Eunice Kennedy Shriver 

National Institute of Child Health and 

Human Development, National Institutes of 

Health, 6710B Rockledge Drive, Room 2131B, 

Bethesda, MD 20892, (301) 451–0000, 

jolanta.topczewska@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children, 

National Institutes of Health, HHS) 

Dated: July 15, 2021. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–15447 Filed 7–20–21; 8:45 am] 

BILLING CODE 4140–01–P 


jbell on DSKJLSW7X2PROD with NOTICES